Abstract
Primary central nervous system lymphoma (PCNSL) is an aggressive extranodal non-Hodgkin lymphoma affecting the brain, particularly periventricular areas, leptomeninges, spinal cord, and/or eyes. Immunocompromised patients are at greater risk than immunocompetent individuals especially patients with AIDS. Diagnosis is made through stereotactic needle biopsy. Cerebrospinal fluid analysis and victrectomy or choroidal/retinal biopsy may be sufficient to render the diagnosis. CNS staging requires evaluating the extent of disease and systemic disease must be ruled out prior to initiating treatment. Chemotherapy using a high dose HD-MTX based regimen is the first line of treatment.
| Original language | English |
|---|---|
| Title of host publication | Oncology |
| Publisher | wiley |
| Pages | 364-375 |
| Number of pages | 12 |
| ISBN (Electronic) | 9781119189596 |
| ISBN (Print) | 9781119189558 |
| DOIs | |
| State | Published - 30 Aug 2019 |
Keywords
- AIDS
- Diffuse large b-cell
- Leptomeningeal
- Lymphoma
- Methotrexate
- Ocular
- PCNSL
Fingerprint
Dive into the research topics of 'Primary central nervous system lymphoma'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver